Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8765 | 1219 | 33.7 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
2612 | 2 | WARBURG EFFECT//PKM2//PYRUVATE KINASE | 3575 |
8765 | 1 | PKM2//PYRUVATE KINASE//PYRUVATE KINASE DEFICIENCY | 1219 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PKM2 | authKW | 1626217 | 7% | 73% | 89 |
2 | PYRUVATE KINASE | authKW | 1255125 | 12% | 33% | 152 |
3 | PYRUVATE KINASE DEFICIENCY | authKW | 953962 | 4% | 81% | 47 |
4 | PYRUVATE KINASE M2 | authKW | 612469 | 3% | 68% | 36 |
5 | TUMOR M2 PYRUVATE KINASE | authKW | 475910 | 2% | 100% | 19 |
6 | TUM2 PK | authKW | 350671 | 1% | 100% | 14 |
7 | TUMOR M2 PK | authKW | 302362 | 1% | 93% | 13 |
8 | PK LR GENE | authKW | 200383 | 1% | 100% | 8 |
9 | M2 PK | authKW | 114498 | 1% | 57% | 8 |
10 | PKLR GENE MUTATIONS | authKW | 100192 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 3228 | 44% | 0% | 533 |
2 | Hematology | 2000 | 13% | 0% | 158 |
3 | Oncology | 1011 | 17% | 0% | 202 |
4 | Cell Biology | 699 | 14% | 0% | 170 |
5 | Biophysics | 641 | 9% | 0% | 113 |
6 | Medical Laboratory Technology | 95 | 2% | 0% | 21 |
7 | Genetics & Heredity | 84 | 5% | 0% | 60 |
8 | Medicine, Research & Experimental | 73 | 4% | 0% | 50 |
9 | Gastroenterology & Hepatology | 47 | 3% | 0% | 33 |
10 | Biochemical Research Methods | 32 | 3% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM ENDOCRINOL | 77230 | 1% | 19% | 16 |
2 | PL HUMAN GENET | 52892 | 1% | 16% | 13 |
3 | PHARMA ETH | 50096 | 0% | 100% | 2 |
4 | W KENT CANC NETWORK | 50096 | 0% | 100% | 2 |
5 | TRANSFUS MED CELL PROC | 34672 | 0% | 23% | 6 |
6 | SE LONDON CANC NETWORK | 33396 | 0% | 67% | 2 |
7 | ZENTRAL OR ZENTRUM INNERE MED | 33396 | 0% | 67% | 2 |
8 | BIOCHEM ENDOKRINOL | 30725 | 1% | 14% | 9 |
9 | ABORAT INNOVAT CANC PERSONALIZED MEDCANC | 25048 | 0% | 100% | 1 |
10 | ABT MED INFORMAT BIOMET EPIDEMIOL | 25048 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF HEMATOLOGY | 2812 | 2% | 0% | 26 |
2 | CANADIAN JOURNAL OF BIOCHEMISTRY | 2660 | 1% | 2% | 7 |
3 | BLOOD CELLS MOLECULES AND DISEASES | 2012 | 1% | 1% | 12 |
4 | COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY | 1740 | 2% | 0% | 26 |
5 | ANTICANCER RESEARCH | 1465 | 3% | 0% | 34 |
6 | BRITISH JOURNAL OF HAEMATOLOGY | 1414 | 2% | 0% | 28 |
7 | INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 1375 | 1% | 0% | 13 |
8 | INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING | 1101 | 0% | 1% | 6 |
9 | BIOCHEMISTRY | 1055 | 4% | 0% | 49 |
10 | CLINICS IN HAEMATOLOGY | 842 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PKM2 | 1626217 | 7% | 73% | 89 | Search PKM2 | Search PKM2 |
2 | PYRUVATE KINASE | 1255125 | 12% | 33% | 152 | Search PYRUVATE+KINASE | Search PYRUVATE+KINASE |
3 | PYRUVATE KINASE DEFICIENCY | 953962 | 4% | 81% | 47 | Search PYRUVATE+KINASE+DEFICIENCY | Search PYRUVATE+KINASE+DEFICIENCY |
4 | PYRUVATE KINASE M2 | 612469 | 3% | 68% | 36 | Search PYRUVATE+KINASE+M2 | Search PYRUVATE+KINASE+M2 |
5 | TUMOR M2 PYRUVATE KINASE | 475910 | 2% | 100% | 19 | Search TUMOR+M2+PYRUVATE+KINASE | Search TUMOR+M2+PYRUVATE+KINASE |
6 | TUM2 PK | 350671 | 1% | 100% | 14 | Search TUM2+PK | Search TUM2+PK |
7 | TUMOR M2 PK | 302362 | 1% | 93% | 13 | Search TUMOR+M2+PK | Search TUMOR+M2+PK |
8 | PK LR GENE | 200383 | 1% | 100% | 8 | Search PK+LR+GENE | Search PK+LR+GENE |
9 | M2 PK | 114498 | 1% | 57% | 8 | Search M2+PK | Search M2+PK |
10 | PKLR GENE MUTATIONS | 100192 | 0% | 100% | 4 | Search PKLR+GENE+MUTATIONS | Search PKLR+GENE+MUTATIONS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LI, ZW , YANG, P , LI, ZY , (2014) THE MULTIFACETED REGULATION AND FUNCTIONS OF PKM2 IN TUMOR PROGRESSION.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1846. ISSUE 2. P. 285 -296 | 99 | 73% | 17 |
2 | WONG, N , OJO, D , YAN, J , TANG, D , (2015) PKM2 CONTRIBUTES TO CANCER METABOLISM.CANCER LETTERS. VOL. 356. ISSUE 2. P. 184 -191 | 66 | 78% | 32 |
3 | ISRAELSEN, WJ , VANDER HEIDEN, MG , (2015) PYRUVATE KINASE: FUNCTION, REGULATION AND ROLE IN CANCER.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. VOL. 43. ISSUE . P. 43 -51 | 64 | 82% | 17 |
4 | CANU, G , DE BONIS, M , MINUCCI, A , CAPOLUONGO, E , (2016) RED BLOOD CELL PK DEFICIENCY: AN UPDATE OF PK-LR GENE MUTATION DATABASE.BLOOD CELLS MOLECULES AND DISEASES. VOL. 57. ISSUE . P. 100 -109 | 62 | 97% | 1 |
5 | GUPTA, V , WELLEN, KE , MAZUREK, S , BAMEZAI, RNK , (2014) PYRUVATE KINASE M2: REGULATORY CIRCUITS AND POTENTIAL FOR THERAPEUTIC INTERVENTION.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 15. P. 2595-2606 | 75 | 82% | 5 |
6 | CHANETON, B , GOTTLIEB, E , (2012) ROCKING CELL METABOLISM: REVISED FUNCTIONS OF THE KEY GLYCOLYTIC REGULATOR PKM2 IN CANCER.TRENDS IN BIOCHEMICAL SCIENCES. VOL. 37. ISSUE 8. P. 309-316 | 55 | 92% | 79 |
7 | ZANELLA, A , FERMO, E , BIANCHI, P , VALENTINI, G , (2005) RED CELL PYRUVATE KINASE DEFICIENCY: MOLECULAR AND CLINICAL ASPECTS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 130. ISSUE 1. P. 11-25 | 72 | 94% | 73 |
8 | MAZUREK, S , (2011) PYRUVATE KINASE TYPE M2: A KEY REGULATOR OF THE METABOLIC BUDGET SYSTEM IN TUMOR CELLS.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 43. ISSUE 7. P. 969-980 | 66 | 56% | 225 |
9 | IQBAL, MA , GUPTA, V , GOPINATH, P , MAZUREK, S , BAMEZAI, RNK , (2014) PYRUVATE KINASE M2 AND CANCER: AN UPDATED ASSESSMENT.FEBS LETTERS. VOL. 588. ISSUE 16. P. 2685 -2692 | 61 | 73% | 36 |
10 | ZANELLA, A , FERMO, E , BIANCHI, P , CHIARELLI, LR , VALENTINI, G , (2007) PYRUVATE KINASE DEFICIENCY: THE GENOTYPE-PHENOTYPE ASSOCIATION.BLOOD REVIEWS. VOL. 21. ISSUE 4. P. 217 -231 | 61 | 95% | 39 |
Classes with closest relation at Level 1 |